<DOC>
	<DOCNO>NCT00827515</DOCNO>
	<brief_summary>Initial study use powder capsule formulation PH797804 . In future study immediate release tablet use . The purpose study compare blood level PH797804 follow oral dose powder capsule formulation tablet formulation . In addition effect food blood level PH797804 investigate</brief_summary>
	<brief_title>Relative Bioavailability Food Effect Study</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject age 21 55 year Healthy define clinical relevant abnormality identify detailed medical history , full physical examination include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test Willing use acceptable method contraception outline study protocol Body mass index 18 30 kg/m2 Subjects willing able comply schedule visit , treatment plan study procedure Subjects evidence history clinically significant disease Pregnant nursing female Females childbearing potential unwilling unable use acceptable method nonhormonal contraception least 14 day prior first dose day 15 period 4 Subjects condition possibly affect drug absorption ( eg gastrectomy ) A positive approve immunoassay/ELISA blood test TB Subjects history regular alcohol consumption exceed 14 drinks/week female 21 drinks/week men Subjects use prescription nonprescription drug , vitamin and/or dietary supplement within 7 day 5 halflives ( whichever longer ) prior first dose study medication Subjects administer medication capable induce hepatic enzyme metabolism ( eg barbiturate , rifampin , carbamazepine , phenytoin primidone ) within 14 day ( 5 halflives induce agent , whichever long ) day 1 within 28 day administration St John 's wort</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Relative Bioavailability Effect food</keyword>
</DOC>